# FDA Inspection 1021839 - Biomat USA Inc - August 03, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7ea5c8a2-a4f0-4860-a529-59da3567cc8a
Source feed: FDA_Inspections

> FDA Inspection 1021839 for Biomat USA Inc on August 03, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021839
- Company Name: Biomat USA Inc
- Inspection Date: 2017-08-03
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1260001 - 2025-01-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ad550ba2-408d-4583-bac2-8261f1598120)
- [FDA Inspection 1260001 - 2025-01-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b1242c9a-263e-451d-a4a1-2ea8c767b682)
- [FDA Inspection 843831 - 2013-08-08](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c159fd7e-6c0e-467f-bdb1-e3a22f53a2a0)
- [FDA Inspection 730631 - 2011-06-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/425160ee-36ed-4811-8a39-e0a3a34302f0)
- [FDA Inspection 572528 - 2009-03-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a583976d-36f4-4d57-b5a7-920cd307bd57)

Company: https://www.keypedia.com/companies/biomat-usa-inc/77139b4f-1187-4e12-9126-2e861ae5dd9f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d